Projects per year
Personal profile
Headline
ASSOCIATE PROFESSOR Medicine, Hematology, and Medical Oncology
Biography
Fingerprint
Dive into the research topics where Yelena Ginzburg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Regulatory Role of Transferrin in Erythropoiesis and Iron Metabolism
Fleming, R. R. E., Fleming, R. E., Rivella, S., Rivella, S. S. & Ginzburg, Y.
National Institute of Diabetes and Digestive and Kidney Diseases
28/09/12 → 30/04/23
Project: Research
-
Dysregulated iron metabolism plays a pivotal role in polycythemia vera
1/01/19 → 31/12/21
Project: Research
-
Understand and Improve Iron Distribution and Erythropoiesis in Beta-Thalassemia
National Heart, Lung, and Blood Institute
15/02/11 → 31/01/16
Project: Research
-
Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease
Li, H., Kazmi, J. S., Lee, S., Zhang, D., Gao, X., Maryanovich, M., Torres, L., Verma, D., Kelly, L., Ginzburg, Y. Z., Frenette, P. S. & Manwani, D., 12 Jan 2023, In: Blood. 141, 2, p. 194-199 6 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
ATR inhibitor camonsertib (RP-3500) suppresses early-stage erythroblasts by mediating ferroptosis
Levy, M., Ferraro, G. B., Planoutene, M., Li, L., Han, Y., Varicchio, L., Fournier, S., An, X., Morris, S. J., Koehler, M., Hoffman, R., Fretland, A. J., Roulston, A. & Ginzburg, Y. Z., Oct 2022, In: European Journal of Cancer. 174, p. S100Research output: Contribution to journal › Article › peer-review
Open Access -
MPN-469 Rusfertide (PTG-300) Treatment Interruption Reverses Hematological Gains and Upon Reinitiation, Restoration of Clinical Benefit Observed in Patients With Polycythemia Vera
Pemmaraju, N., Kuykendall, A., Kremyanskaya, M., Ginzburg, Y., Ritchie, E., Gotlib, J., Gerds, A., Palmer, J., Valone, F., O'Connor, P., Modi, N., Gupta, S., Hoffman, R. & Verstovsek, S., Oct 2022, In: Clinical Lymphoma, Myeloma and Leukemia. 22, p. S338-S339Research output: Contribution to journal › Article › peer-review
-
The addition of oral iron improves chemotherapy-induced anemia in patients receiving erythropoiesis-stimulating agents
Tan, J., Du, S., Zang, X., Ding, K., Ginzburg, Y. & Chen, H., 1 Nov 2022, In: International Journal of Cancer. 151, 9, p. 1555-1564 10 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Clinical insights into the origins of thrombosis in myeloproliferative neoplasms
Moliterno, A. R., Ginzburg, Y. Z. & Hoffman, R., 4 Mar 2021, In: Blood. 137, 9, p. 1145-1153 9 p.Research output: Contribution to journal › Review article › peer-review
Open Access25 Scopus citations
Press / Media
-
Protagonist Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Yelena Ginzburg & Ronald Hoffman
4/08/22
61 items of Media coverage
Press/Media
-
Von Willebrand factor A1 domain stability and affinity for GPIbα are differentially regulated by its O-glycosylated N- and C-linker
9/05/22
1 item of Media coverage
Press/Media
-
Discipline Spotlight: Publishing metabolism research at eLife
Christoph Buettner, Yelena Ginzburg, Paul Wassarman, Tony Yuen, Mone Zaidi & Edward Fisher,
20/04/22
1 item of Media coverage
Press/Media
-
Rusfertide Lowers Hematocrit in Patients With Polcythemia Vera
14/01/22
1 item of Media coverage
Press/Media
-
Aging is associated with increased brain iron through cortex-derived hepcidin expression
11/01/22
1 item of Media coverage
Press/Media